Benzoylecgonine hydrochloride | 39426-98-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: Benzoylecgonine hydrochloride
• 英文别名: (1R,2R,3S,5S)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid;hydrochloride
• CAS: 39426-98-7
• 化学式: C16H20ClNO4
• 分子量: 325.79
• InChiKey: CMSMPZLAQCHUGM-BHARVXRSSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  22
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  66.8
• 氢给体数：
  2
• 氢受体数：
  5

文献信息

• Method and device for obtaining and detecting immunologically active substances from the gas phase
  申请人：Securetec Detektions-Systeme AG

  公开号：US20040023289A1

  公开（公告）日：2004-02-05

  A method is disclosed for obtaining and/or immunologically detecting an analyte contained in a gas phase by immunologically binding the analyte to a binding partner thereof contained in a gas- and liquid-permeable first carrier matrix. Said method is characterized in that a) the analyte-containing gas phase is brought into contact with the first carrier matrix (immune adsorber), b) the analyte is bound to the first binding partner which is contained in the first matrix and not bound to the matrix, and c) the complex of analyte and first binding partner and the free first binding partner are eluted from the first matrix, d) the eluted complex or the free first binding partner is determined as a measure for the amount of analyte present.
• PREPARATION OF (-)-COCAINE HYDROCHLORIDE
  申请人：Cody Laboratories, Inc.

  公开号：US20190224185A1

  公开（公告）日：2019-07-25

  Efficient methods are provided for large scale production of ethyl cocaine-free cocaine hydrochloride. Compositions and methods comprising administration of cocaine hydrochloride are provided.
• US6605444B1
  申请人：——

  公开号：US6605444B1

  公开（公告）日：2003-08-12
• [EN] PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING<br/>[ES] COMPOSICIÓN FARMACEUTICA PARA LA PREVENCIÓN Y TRATAMIENTO DE LAS ADICCIONES A TRAVES DE UN CONTRACONDICIONAMIENTO AVERSIVO<br/>[FR] COMPOSITION PHARMACEUTIQUE POUR LA PRÉVENTION ET LE TRAITEMENT DES ADDICTIONS À TRAVERS UN CONTRE-CONDITIONNEMENT AVERSIF
  申请人：SERANI MOSTAZAL JORGE

  公开号：WO2018145219A1

  公开（公告）日：2018-08-16

  Una composición farmacéutica que comprende una o más sustancias adictivas y/o uno o más odorantes y/o uno o más agentes aversivos, cada uno de estos como principios activos o como sales, esteres, polimorfos, isómeros, enantiómeros, prodrogas, solvatos, hidratos o derivados, farmacéuticamente aceptados, junto con excipientes aceptados y en donde la composición se utiliza para tratar o prevenir las adicciones a través de un contracondicionamiento aversivo.